John W. Steinke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John W. Steinke has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Larry Borish
Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, United States of America
12 shared publications- Larry Borish
Division of Asthma, Allergy, and Immunology, Department of Medicine; Department of Microbiology; Beirne Carter Immunology Center, University of Virginia Department of Statistics
4 shared publications Elizabeth Barekzi
3 shared publicationsJulie Negri
Asthma and Allergic Disease Center, University of Virginia Health System, Charlottesville, VA
3 shared publicationsKathleen Hise
Asthma and Allergic Disease Center, Beirne Carter Center for Immunology Research, Departments of Medicine, University of Virginia Health System, Charlottesville, Virginia
3 shared publicationsPhillip Huyett
Asthma and Allergic Disease Center, University of Virginia Health System, Charlottesville, VA 22908
3 shared publications
Latest Publications
- 1 October 2019
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 123  (4) , 333-334
Aspirin desensitization or biologics for AERD?
- 1 October 2019
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 123  (4) , 333-334
Aspirin desensitization or biologics for AERD?
- Open Access
- 15 August 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14  (8) , e0221113
Expression of IL-5 receptor alpha by murine and human lung neutrophils
The role of eosinophilia in atopic diseases, including asthma, is well established, as is the well-known role of IL-5 as a major eosinophilopoeitin and chemoattractant. Following influenza A virus infection of mice, type 2 innate lymphoid cells are recruited to the respiratory tract and produce large quantities of IL-5, which contributes to the recruitment of eosinophils into the infected lungs during the recovery phase of infection. We demonstrate here that while IL-5 is required for optimal recovery from influenza A virus infection in BALB/c and C57BL/6 mice, the protective effect of IL-5 is independent of eosinophils, suggesting an alternative cellular target. We describe the unexpected finding of IL-5 receptor alpha (CD125) expression on neutrophils infiltrating the inflamed mouse lungs, as well as on neutrophils at other anatomic sites. We extend this finding of neutrophil CD125 expression to humans, specifically to neutrophils found in the bronchoalveolar lavage fluid from the inflamed lungs of children with treatment-refractory asthma. We further demonstrate that the IL-5 receptor on neutrophils is capable of signal transduction. Our data provide further evidence that neutrophils can play a role bridging atopic type 2 and innate anti-microbial immunity.
- 15 August 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14  (8) , e0221113
Open AccessExpression of IL-5 receptor alpha by murine and human lung neutrophils
The role of eosinophilia in atopic diseases, including asthma, is well established, as is the well-known role of IL-5 as a major eosinophilopoeitin and chemoattractant. Following influenza A virus infection of mice, type 2 innate lymphoid cells are recruited to the respiratory tract and produce large quantities of IL-5, which contributes to the recruitment of eosinophils into the infected lungs during the recovery phase of infection. We demonstrate here that while IL-5 is required for optimal recovery from influenza A virus infection in BALB/c and C57BL/6 mice, the protective effect of IL-5 is independent of eosinophils, suggesting an alternative cellular target. We describe the unexpected finding of IL-5 receptor alpha (CD125) expression on neutrophils infiltrating the inflamed mouse lungs, as well as on neutrophils at other anatomic sites. We extend this finding of neutrophil CD125 expression to humans, specifically to neutrophils found in the bronchoalveolar lavage fluid from the inflamed lungs of children with treatment-refractory asthma. We further demonstrate that the IL-5 receptor on neutrophils is capable of signal transduction. Our data provide further evidence that neutrophils can play a role bridging atopic type 2 and innate anti-microbial immunity.
- 25 June 2019
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 33  (6) , 665-670
Differential Expression of Extracellular Matrix Components in Nasal Polyp Endotypes
Background: Chronic rhinosinusitis is a difficult-to-treat disease that is often characterized by recurrent nasal polyp (NP) growth following surgical removal. The disease has been separated into distinct phenotypes based on cellular infiltrate or underlying physiological mechanisms. NPs are composed in part of an inflammatory cellular infiltrate, blood vessels, and a large amount of extracellular matrix (ECM). Despite the recognition of prominent ECM deposition, few studies have examined the components in detail and how they might differ with disease state. Objective: The purpose of this study was to quantitate the expression of ECM components in NPs. Methods: NPs were stained with pico-sirius red to determine total collagen content, and immunofluorescence was used to detect collagen I, collagen III, collagen IV, fibronectin, and laminin. Expression of each was quantitated and analyzed in relation to rhinosinusitis phenotype and separately as a function of polyp eosinophil number. Results: When analyzed by phenotype, collagen I, collagen III, and fibronectin were expressed at the highest levels in noneosinophilic sinus disease. Collagen IV was not different among any groups, and its location was found predominately around vessels. When analyzed as a function of polyp eosinophil number, total collagen and collagen III showed a significant inverse correlation. Conclusions: NP ECM composition differs with disease state with higher expression in cases where eosinophil levels are low. This suggests that in eosinophilic polyps there is a loss of matrix deposition either through break down or a failure to produce the essential components. Understanding these differences may identify new therapeutic targets.
- 25 June 2019
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 33  (6) , 665-670
Differential Expression of Extracellular Matrix Components in Nasal Polyp Endotypes
Background: Chronic rhinosinusitis is a difficult-to-treat disease that is often characterized by recurrent nasal polyp (NP) growth following surgical removal. The disease has been separated into distinct phenotypes based on cellular infiltrate or underlying physiological mechanisms. NPs are composed in part of an inflammatory cellular infiltrate, blood vessels, and a large amount of extracellular matrix (ECM). Despite the recognition of prominent ECM deposition, few studies have examined the components in detail and how they might differ with disease state. Objective: The purpose of this study was to quantitate the expression of ECM components in NPs. Methods: NPs were stained with pico-sirius red to determine total collagen content, and immunofluorescence was used to detect collagen I, collagen III, collagen IV, fibronectin, and laminin. Expression of each was quantitated and analyzed in relation to rhinosinusitis phenotype and separately as a function of polyp eosinophil number. Results: When analyzed by phenotype, collagen I, collagen III, and fibronectin were expressed at the highest levels in noneosinophilic sinus disease. Collagen IV was not different among any groups, and its location was found predominately around vessels. When analyzed as a function of polyp eosinophil number, total collagen and collagen III showed a significant inverse correlation. Conclusions: NP ECM composition differs with disease state with higher expression in cases where eosinophil levels are low. This suggests that in eosinophilic polyps there is a loss of matrix deposition either through break down or a failure to produce the essential components. Understanding these differences may identify new therapeutic targets.
- 1 April 2018
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 120  (4) , 376-381
Cytokine-targeting biologics for allergic diseases
- 1 April 2018
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 120  (4) , 376-381
Cytokine-targeting biologics for allergic diseases
- 1 March 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6  (2) , 677-679
Food allergen component proteins are not detected in early-childhood vaccines
- 1 March 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6  (2) , 677-679
Food allergen component proteins are not detected in early-childhood vaccines
- Open Access
- 1 February 2017
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139  (2) , AB155
Local IgE Production in Allergic (AR) and Non-Allergic Rhinitis (NAR)
- 1 February 2017
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139  (2) , AB155
Open AccessLocal IgE Production in Allergic (AR) and Non-Allergic Rhinitis (NAR)
- 1 October 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138  (4) , 1089-1097.e3
Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease
- 1 October 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138  (4) , 1089-1097.e3
Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease
- Open Access
- 1 March 2016
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 9, 37-43
Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
Asthma and chronic rhinosinusitis are heterogeneous airway diseases of the lower and upper airways, respectively. Molecular and cellular studies indicate that these diseases can be categorized into unique endotypes, which have therapeutic implications. One such endotype is aspirin-exacerbated respiratory disease (AERD), which encompasses the triad of asthma, aspirin (or nonsteroidal anti-inflammatory drug) hypersensitivity, and nasal polyposis. AERD has unique pathophysiological features that distinguish it from aspirin-tolerant asthma and other forms of chronic rhinosinusitis. This review details molecular and cellular features of AERD and highlights current and future therapies that are based on these insights.
- 1 March 2016
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 9, 37-43
Open AccessAspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
Asthma and chronic rhinosinusitis are heterogeneous airway diseases of the lower and upper airways, respectively. Molecular and cellular studies indicate that these diseases can be categorized into unique endotypes, which have therapeutic implications. One such endotype is aspirin-exacerbated respiratory disease (AERD), which encompasses the triad of asthma, aspirin (or nonsteroidal anti-inflammatory drug) hypersensitivity, and nasal polyposis. AERD has unique pathophysiological features that distinguish it from aspirin-tolerant asthma and other forms of chronic rhinosinusitis. This review details molecular and cellular features of AERD and highlights current and future therapies that are based on these insights.
- 1 January 2016
- Published by Springer Nature
- p. 416-433
Cytokines
- Open Access
- 13 January 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10  (1) , e0115271
Immune Surveillance by Rhinovirus-Specific Circulating CD4+ and CD8+ T Lymphocytes
It is difficult to experimentally infect volunteers with RV strains to which the subject demonstrates serological immunity. However, in RV challenges, viral clearance begins before de novo adaptive immune responses would develop. We speculated that adaptive immunity to RV reflects heterologous immunity by effector memory cells. DCs were generated from monocytes using GM-CSF and IL-4 and RV39 loading accomplished with a dose of ∼350 TCID50/105 cells. RV-induced maturation was established as modulation of MHC class II, CD80, CD83, and CD86. Circulating RV targeting CD4 and CD8 T cells were investigated as induction of RV-specific proliferation (CFSE-dilution). Maturation of DC by RV was confirmed as upregulation of MHC Class II (83.3±5.0% to 87.8±4.1%), CD80 (39.4±7.2% to 47.6±7.7%) and CD86 (78.4±4.7% to 84.1±3.4%). Both CD4 and CD8 memory T cells were recognized in the circulation of healthy subjects. RV drives DC maturation and results in their ability to present RV antigens to both T helper and cytotoxic lymphocytes. Both CD4 and CD8 cells capable of recognizing RV-associated antigens are present in the circulation of healthy subjects where they are presumably involved in immune surveillance and explain the rapid recruitment of an adaptive immune response during RV infection.
- 13 January 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10  (1) , e0115271
Open AccessImmune Surveillance by Rhinovirus-Specific Circulating CD4+ and CD8+ T Lymphocytes
It is difficult to experimentally infect volunteers with RV strains to which the subject demonstrates serological immunity. However, in RV challenges, viral clearance begins before de novo adaptive immune responses would develop. We speculated that adaptive immunity to RV reflects heterologous immunity by effector memory cells. DCs were generated from monocytes using GM-CSF and IL-4 and RV39 loading accomplished with a dose of ∼350 TCID50/105 cells. RV-induced maturation was established as modulation of MHC class II, CD80, CD83, and CD86. Circulating RV targeting CD4 and CD8 T cells were investigated as induction of RV-specific proliferation (CFSE-dilution). Maturation of DC by RV was confirmed as upregulation of MHC Class II (83.3±5.0% to 87.8±4.1%), CD80 (39.4±7.2% to 47.6±7.7%) and CD86 (78.4±4.7% to 84.1±3.4%). Both CD4 and CD8 memory T cells were recognized in the circulation of healthy subjects. RV drives DC maturation and results in their ability to present RV antigens to both T helper and cytotoxic lymphocytes. Both CD4 and CD8 cells capable of recognizing RV-associated antigens are present in the circulation of healthy subjects where they are presumably involved in immune surveillance and explain the rapid recruitment of an adaptive immune response during RV infection.